Which pharmaceutical company's 2012 product launch revolutionized Hepatitis C treatment by introducing the first all-oral regimen with cure rates exceeding 90%, eliminating the need for interferon injections?

The medical industry has seen numerous revolutionary product launches that have transformed healthcare delivery and patient outcomes. From cutting-edge diagnostic tools to innovative therapeutic devices, these launches often represent years of R&D, clinical trials, and regulatory navigation. This trivia question focuses on a particularly noteworthy medical product launch that changed treatment paradigms. Test your knowledge of medical industry milestones!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Gilead Sciences with Sovaldi (sofosbuvir)
Merck with Zepatier (elbasvir/grazoprevir)
AbbVie with Viekira Pak (ombitasvir/paritaprevir/ritonavir)
Bristol-Myers Squibb with Daklinza (daclatasvir)